Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hubert Blum

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Deutsche Medizinische Wochenschrift (1946)|July 17, 2015
[A global problem: chronic liver disease]Hubert Blum
Journal of Gastroenterology and Hepatology|April 10, 2016
Platelet count to spleen diameter ratio non-invasively identifies severe fibrosis and cirrhosis in patients with autoimmune hepatitisAnna Sheptulina, Elena Shirokova, Tatiana Nekrasova, et al.
European Journal of Gastroenterology & Hepatology|May 14, 2010
Acute hepatitis after autologous stem cell transplantation and rapid progression to liver cirrhosisStefan Zschiedrich, Richard Fischer, Annette Schmitt-Gräff, et al.
Gastroenterology|May 13, 2008
Therapeutic vaccination of chronic hepatitis C nonresponder patients with the peptide vaccine IC41Christoph S Klade, Heiner Wedemeyer, Thomas Berg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 20, 2007
Phase I clinical study of AZD2171, an oral vascular endothelial growth factor signaling inhibitor, in patients with advanced solid tumorsJoachim Drevs, Patrizia Siegert, Michael Medinger, et al.
Journal of Angiogenesis Research|December 1, 2009
DCE-MRI assessment of the effect of vandetanib on tumor vasculature in patients with advanced colorectal cancer and liver metastases: a randomized phase I studyKlaus Mross, Ulrike Fasol, Annette Frost, et al.
Cancer Cell|September 28, 2025
A Lymphotoxin-Driven Pathway to Hepatocellular CarcinomaJohannes Haybaeck, Nicolas Zeller, Monika Julia Wolf, et al.
Cancer Cell|October 6, 2009
A lymphotoxin-driven pathway to hepatocellular carcinomaJohannes Haybaeck, Nicolas Zeller, Monika Julia Wolf, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Deutsche Medizinische Wochenschrift (1946)|July 17, 2015
[A global problem: chronic liver disease]Hubert Blum
Journal of Gastroenterology and Hepatology|April 10, 2016
Platelet count to spleen diameter ratio non-invasively identifies severe fibrosis and cirrhosis in patients with autoimmune hepatitisAnna Sheptulina, Elena Shirokova, Tatiana Nekrasova, et al.
European Journal of Gastroenterology & Hepatology|May 14, 2010
Acute hepatitis after autologous stem cell transplantation and rapid progression to liver cirrhosisStefan Zschiedrich, Richard Fischer, Annette Schmitt-Gräff, et al.
Gastroenterology|May 13, 2008
Therapeutic vaccination of chronic hepatitis C nonresponder patients with the peptide vaccine IC41Christoph S Klade, Heiner Wedemeyer, Thomas Berg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 20, 2007
Phase I clinical study of AZD2171, an oral vascular endothelial growth factor signaling inhibitor, in patients with advanced solid tumorsJoachim Drevs, Patrizia Siegert, Michael Medinger, et al.
Journal of Angiogenesis Research|December 1, 2009
DCE-MRI assessment of the effect of vandetanib on tumor vasculature in patients with advanced colorectal cancer and liver metastases: a randomized phase I studyKlaus Mross, Ulrike Fasol, Annette Frost, et al.
Cancer Cell|September 28, 2025
A Lymphotoxin-Driven Pathway to Hepatocellular CarcinomaJohannes Haybaeck, Nicolas Zeller, Monika Julia Wolf, et al.
Cancer Cell|October 6, 2009
A lymphotoxin-driven pathway to hepatocellular carcinomaJohannes Haybaeck, Nicolas Zeller, Monika Julia Wolf, et al.
Pageof 1